xconomy.com xconomy.com - The score is 60/100

Website Review: xconomy.com

 Generated on October 15 2026 13:45 PM

Old data? UPDATE !

The score is 60/100





Advertisement

SEO Content

Title

BioXconomy

Length : 10

Your title's length should be between 40 and 70 characters. The optimal title length is between 50 to 70 chars. Rewrite the title tag to fit this range, or use our free meta tag generator.

Description

BioXconomy provides information and insights for life sciences investment, innovation and partnering.

Length : 101

Great, your meta description tag's length is between 90 and 160 characters. A description tag of 155 to 160 characters is optimal.

Keywords

Not good (but low priority). We haven't found a meta keywords tag on your page. You can add a meta keywords tag to the page's <head> with our free meta tag generator.

Og Meta Properties

Good, your page takes advantage of Open Graph Properties. Open Graph properties can help with indexing.

Property Content
title BioXconomy
description BioXconomy provides information and insights for life sciences investment, innovation and partnering.
url https://www.bioxconomy.com/
type website
image https://eu-images.contentstack.com/v3/assets/blt72fb3b8b4630b7db/blt25617c776391716f/6a7e58393f96871c9f61f984/BioXconomy-opengraph-2.jpg?disable=upscale&width=1200&height=630&fit=crop
site_name BioXconomy

Headings

H1 H2 H3 H4 H5 H6
0 3 9 8 4 0
  • [H2] Latest News
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H3] IgniteData, RealTime eClinical Solutions announce data transfer partnership
  • [H3] OMass bags $310m to push rare disease drugs forward
  • [H3] Zealand Pharma generates metabolic therapeutics with AI platform
  • [H3] Bluesky and X users share clinical trial information in markedly different ways, new research shows
  • [H3] Dose of Discovery Podcast, Season 1
  • [H3] Watch the latest presentations coming from our recent partnering events
  • [H3] News from APAC
  • [H3] Interviews
  • [H3] AI in Life Sciences
  • [H4] Related Topics
  • [H4] Recent in Partnering
  • [H4] Related Topics
  • [H4] Recent in Investment
  • [H4] Related Topics
  • [H4] Recent in Modalities
  • [H4] Related Topics
  • [H4] Recent in Business Strategy
  • [H5] Resources
  • [H5] Connect
  • [H5] Join Us
  • [H5] Follow Us

Images

We found 54 images on this web page.

4 image alt attributes were missing. Please add alt text to all images to help search engines better understand the content of your images.

Text/HTML Ratio

Ratio : 3%

This page's ratio of text to HTML code is below 20 percent, this means that your website probably needs more text content in order to do well in search engines. Note: This may also result from a false reading due to your server blocking external scripts from accessing the home page.

Iframe

Not ideal - You have Iframes on the web page, this mean that content in an Iframe cannot be indexed.

URL Rewrite

Good. Your links look SEO friendly and are easy to crawl!

Underscores in the URLs

Great! No underscores found in your URLs.

In-page links

We found a total of 73 links including 0 link(s) to files

Anchor Type Juice
Informa PLC External Passing Juice
ABOUT US External Passing Juice
INVESTOR RELATIONS External Passing Juice
TALENT External Passing Juice
About Internal Passing Juice
Events Internal Passing Juice
Advertise External Passing Juice
Licensing Internal Passing Juice
M&A Internal Passing Juice
Growth Strategy Internal Passing Juice
Partnering Internal Passing Juice
Zealand Pharma generates metabolic therapeutics with AI platform Internal Passing Juice
Nnenna Ohaka Internal Passing Juice
Danaher and NVIDIA partner on AI-driven lab automation Internal Passing Juice
Millie Nelson Internal Passing Juice
VC/PE Internal Passing Juice
Seed Funding Internal Passing Juice
IPOs Internal Passing Juice
Investment Internal Passing Juice
OMass bags $310m to push rare disease drugs forward Internal Passing Juice
Stryker bets big on robot surgery, backing CMR Surgical in $400m deal Internal Passing Juice
Nucleic Acids Internal Passing Juice
Antibodies and Peptides Internal Passing Juice
Advanced Therapies Internal Passing Juice
Modalities Internal Passing Juice
Rethinking Expression to Accelerate Antibody Discovery Internal Passing Juice
Blood-brain barrier repair peptide could hold promise for ALS patients Internal Passing Juice
Søren Hough Internal Passing Juice
Compliance, Regulatory and Legal Internal Passing Juice
Access and Channel Internal Passing Juice
Finance and Accounting Internal Passing Juice
Clinical Trials Internal Passing Juice
Pricing and Contracting Internal Passing Juice
Business Strategy Internal Passing Juice
Optimizing the Affordability Journey: Insights from a Real-World Brand Case Study Internal Passing Juice
IgniteData, RealTime eClinical Solutions announce data transfer partnership Internal Passing Juice
EMA to make EU-level trial advice pilot a permanent option for sponsors Internal Passing Juice
Dose of Discovery: Katalin Karikó on the mRNA breakthrough that changed medicine Internal Passing Juice
Dose of Discovery: Anne Conibear on how small changes reshape peptide and protein biology Internal Passing Juice
Dose of Discovery: Erik Sontheimer on the evolution of genome editing Internal Passing Juice
Dose of Discovery: Cheng Yi Chen on scaling drugs from lab to launch Internal Passing Juice
Dose of Discovery: Stanley Crooke on fixing nano-rare disease with oligos Internal Passing Juice
Dose of Discovery: Julia Alterman on expanding RNA therapeutics Internal Passing Juice
Dose of Discovery: Debut trailer Internal Passing Juice
Eyes on Asia: TCGX, Biohaven, Roche Internal Passing Juice
Shionogi bolsters rare disease portfolio with $2bn IntraBio buy Internal Passing Juice
The hidden cost of going global: How most favored nation pricing is reshaping rare disease launches Internal Passing Juice
Brandy Fidler Internal Passing Juice
SEC-FDA pact tightens disclosure rules for pharma Internal Passing Juice
Lisa Henderson Internal Passing Juice
Medtech firms embrace embedded digital compliance Internal Passing Juice
Tarn Brown Internal Passing Juice
DaltonTx announces AI breakthrough in novel antibody discovery Internal Passing Juice
Millie Hoe Internal Passing Juice
HHS launches initiative to bolster US clinical trials market Internal Passing Juice
Gareth Macdonald Internal Passing Juice
Protect IP theft from vast datasets used in AI Internal Passing Juice
Recruitment challenges, delays, and AI reshaping trials sector, survey finds Internal Passing Juice
Veeva unveils AI agent to speed clinical trial study configuration Internal Passing Juice
Rethinking biotech investment and innovation in a productivity-driven era Internal Passing Juice
Brick by brick: How AI-native biotechs are building investor confidence Internal Passing Juice
How AI is streamlining patient support behind the scenes Internal Passing Juice
AI drug hunter Iambic files for Nasdaq IPO Internal Passing Juice
Enveda’s $311m Series E to fund AI-driven drug discovery Internal Passing Juice
Webinars Internal Passing Juice
Podcasts Internal Passing Juice
Innovation Showcase Internal Passing Juice
Partner Videos Internal Passing Juice
Contribute Internal Passing Juice
About Informa External Passing Juice
Contact Informa External Passing Juice
Privacy External Passing Juice
Terms External Passing Juice
Advertisement

SEO Keywords

Keywords Cloud

chevronright      discovery      lsx      playarrow      now      min      oct      presents      read      dose     

Keywords Consistency

Keyword Content Title Keywords Description Headings
oct 22
discovery 22
lsx 21
min 20
presents 19

Usability

Url

Domain : xconomy.com

Length : 11

Favicon

Great, your website has a favicon.

Language

Good. Your declared language is en.

Document

Doctype

HTML 5

Encoding

Great. Your declared charset is UTF-8.

Email Privacy

Great no email address was found in plain text!

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Not great, your website is using inline styles. This is not optimal.
Not good, your website has too many CSS files (more than 4).
Perfect, your website has few JavaScript files.
Awesome, your website takes advantage of GZIP compression for SEO optimization.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Advertisement

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://www.bioxconomy.com/sitemap.xml
https://www.bioxconomy.com/googlenews.xml
https://www.bioxconomy.com/contributors.xml
https://www.bioxconomy.com/generic-content.xml
https://www.bioxconomy.com/image-archive-index.xml
https://www.bioxconomy.com/news-archive-index.xml
https://www.bioxconomy.com/event-archive-index.xml
https://www.bioxconomy.com/articles-archive-index.xml
https://www.bioxconomy.com/videos-archive-index.xml
https://www.bioxconomy.com/webinar-archive-index.xml
https://www.bioxconomy.com/podcast-archive-index.xml
https://www.bioxconomy.com/multi-section-article-archive-index.xml
https://www.bioxconomy.com/publication-issue-archive-index.xml
https://www.bioxconomy.com/document-archive-index.xml
https://www.bioxconomy.com/sitemap-index.xml
https://www.bioxconomy.com/ads.txt

Robots.txt

http://xconomy.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Missing

Unverified

AI Search Readiness

AI Crawlers

AI search crawlers are allowed, so the site can be shown and cited in AI answers (ChatGPT, Claude, Perplexity).

OAI-SearchBot ChatGPT search AI search
ChatGPT-User ChatGPT (user requests) AI search
Claude-SearchBot Claude search AI search
Claude-User Claude (user requests) AI search
PerplexityBot Perplexity AI search
GPTBot OpenAI training AI training
ClaudeBot Anthropic training AI training
Google-Extended Google Gemini training AI training
Applebot-Extended Apple AI training AI training
CCBot Common Crawl AI training

Blocking AI training crawlers is a common choice and doesn't affect the score. Only the AI search crawlers count.

Structured Data

The homepage describes itself with schema.org structured data, which helps search engines and AI tools understand it: NewsMediaOrganization, ImageObject, QuantitativeValue

Canonical Tag

The homepage has a canonical tag, which tells search engines which URL is the main version of the page.

llms.txt

No llms.txt file. It's an emerging convention: a short Markdown summary of the site for AI tools. Optional, so it doesn't affect the score.

Security

HTTPS

The site loads over HTTPS, so connections are encrypted. Browsers and search engines expect this.

HSTS

The site sends a Strict-Transport-Security header, so browsers always use HTTPS for it.

Security Headers

1 of 5 common security headers found. At least 2 are needed to pass.

Content-Security-Policy
X-Content-Type-Options
X-Frame-Options
Referrer-Policy
Permissions-Policy
Checked on 15 Oct 2026.

Domain Info

xconomy.com was registered on 25 Aug 2006 with SafeNames Ltd. and expires on 25 Aug 2027. It has no mail server (MX) records. The Wayback Machine first archived it in April 2001.

Registration

Registrar SafeNames Ltd.
Registered 25 Aug 2006 (20 years ago)
Expires 25 Aug 2027
Last changed 25 Aug 2026
Nameservers james.ns.cloudflare.com, marge.ns.cloudflare.com
DNSSEC Signed

Hosting

IPv4 address 172.67.128.87, 104.21.0.223
IPv6 support

Email Security

This domain has no mail server (MX) records, so it doesn't receive email.

SPF record
DMARC record (policy: quarantine)

Archive History

The Wayback Machine has snapshots of this site from 189 different months, from April 2001 to February 2026. View snapshots

Domain data checked on 15 Oct 2026. Sources: registry RDAP, public DNS, Internet Archive.

PageSpeed Insights

Device
Categories
Advertisement

GoInfosystems

GoInfosystems is a free SEO site review and rating tool. Get a free review of your site and see areas that may need optimization.